Molecular Medicine: Synthesis and In Vivo Detection of Agents for use in Boron Neutron Capture Therapy. Final Report
- University of Tennessee Graduate School of Medicine
The primary objective of the project was the development of in vivo methods for the detection and evaluation of tumors in humans. The project was focused on utilizing positron emission tomography (PET) to monitor the distribution and pharamacokinetics of a current boron neutron capture therapy (BNCT) agent, p-boronophenylalanine (BPA) by labeling it with a fluorine-18, a positron emitting isotope. The PET data was then used to develop enhanced treatment planning protocols. The study also involved the synthesis of new tumor selective BNCTagents that could be labeled with radioactive nuclides for the in vivo detection of boron.
- Research Organization:
- University of Tennessee Graduate School of Medicine
- Sponsoring Organization:
- USDOE - Office of Energy Research (ER)
- DOE Contract Number:
- FG02-96ER62189
- OSTI ID:
- 909601
- Report Number(s):
- DOE/ER/62189-5
- Country of Publication:
- United States
- Language:
- English
Similar Records
RADIOSYNTHESIS AND CHIRAL SEPARATION OF C-11 LABELED BORONOPHENYLALANINE FOR BNCT STUDIES WITH PET.
Boron Neutron Capture Therapy (BCNT) for the Treatment of Liver Metastases: Biodistribution Studies of Boron Compounds in an Experimental Model
Boron neutron capture therapy of ocular melanoma and intracranial glioma using p-boronophenylalanine
Conference
·
Sun Jun 10 00:00:00 EDT 2001
·
OSTI ID:781788
Boron Neutron Capture Therapy (BCNT) for the Treatment of Liver Metastases: Biodistribution Studies of Boron Compounds in an Experimental Model
Journal Article
·
Mon Feb 28 23:00:00 EST 2011
· Radiation and Environmental Biophysics
·
OSTI ID:1016208
Boron neutron capture therapy of ocular melanoma and intracranial glioma using p-boronophenylalanine
Conference
·
Sun Dec 31 23:00:00 EST 1989
·
OSTI ID:5643007